This could be the next NASDAQ Biotech ready to move in a big way, here's why...
(Nasdaq: CODX) displaying the Holy grail of Bullish signals - a GOLDEN CROSS.
The 50 Day EMA just crossed the 200 Day EMA, which most of you know by now is a bullish signal that indicates a potential breakout is on the Horizon.
Here Is Another Potential "Breakout Catalyst" In Play
Wall Street Analysts at H.C. Wainwright & Maxim Group have both given Co-Diagnostics (Nasdaq: CODX) Buy rating with a $2.00 Price Target, almost double its price at Fridays close, suggesting the stock has a potential upside of +80%.